Compare UUU & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UUU | EVGN |
|---|---|---|
| Founded | 1969 | 1999 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Electronic Components | Agricultural Chemicals |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.8M | 11.1M |
| IPO Year | 2025 | 2013 |
| Metric | UUU | EVGN |
|---|---|---|
| Price | $5.55 | $0.51 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | 42.6K | ★ 296.8K |
| Earning Date | 02-19-2026 | 05-20-2026 |
| Dividend Yield | ★ 16.75% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,847,163.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $73.33 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.02 | $0.37 |
| 52 Week High | $7.82 | $1.50 |
| Indicator | UUU | EVGN |
|---|---|---|
| Relative Strength Index (RSI) | 56.97 | 42.62 |
| Support Level | $4.29 | $0.45 |
| Resistance Level | $6.31 | $0.68 |
| Average True Range (ATR) | 0.65 | 0.03 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 43.19 | 8.94 |
Universal Safety Products Inc designs and markets a variety of popularly priced safety products which, consisted mainly of smoke alarms, carbon monoxide alarms and related products. Its products require minimal installation and are designed for easy installation by the consumer without professional assistance and are sold through retail stores. It also market products to the electrical distribution trade. The electrical distribution trade includes electrical and lighting distributors as well as manufactured housing companies. Products it sell usually require professional installation. Its products are 2-in-1 Smoke & Fire Alarms, 3-in-1 Combo Alarms, and CO Alarms.
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.